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A b s t r a c t
Background: Postoperative atrial fibrillation (POAF) is a leading arrhythmia with high incidence and serious clinical implica-
tions after cardiac surgery. Cardiac surgery is associated with systemic inflammatory response including increase in cytokines 
and activation of endothelial and leukocyte responses. 
Aim This systematic review and meta-analysis aimed to determine the strength of evidence for evaluating the association of 
inflammatory markers, such as C-reactive protein (CRP) and interleukins (IL), with POAF following isolated coronary artery 
bypass grafting (CABG), isolated valvular surgery, or a combination of these procedures.
Methods: We conducted a meta-analysis of studies evaluating measured baseline (from one week before surgical procedures) 
and postoperative levels (until one week after surgical procedures) of inflammatory markers in patients with POAF. A compre-
hensive search was performed in electronic medical databases (Medline/PubMed, Web of Science, Embase, Science Direct, 
and Google Scholar) from their inception through May 2017 to identify relevant studies. A comprehensive subgroup analysis 
was performed to explore potential sources of heterogeneity.
Results: A literature search of all major databases retrieved 1014 studies. After screening, 42 studies were analysed including 
a total of 8398 patients. Pooled analysis showed baseline levels of CRP (standard mean difference [SMD] 0.457 mg/L, p < 0.001), 
baseline levels of IL-6 (SMD 0.398 pg/mL, p < 0.001), postoperative levels of CRP (SMD 0.576 mg/L, p < 0.001), postoperative 
levels of IL-6 (SMD 1.66 pg/mL, p < 0.001), postoperative levels of IL-8 (SMD 0.839 pg/mL, p < 0.001), and postoperative levels 
of IL-10 (SMD 0.590 pg/mL, p < 0.001) to be relevant inflammatory parameters significantly associated with POAF.
Conclusions: Perioperative inflammation is proposed to be involved in the pathogenesis of POAF. Therefore, perioperative 
assessment of CRP, IL-6, IL-8, and IL-10 can help clinicians in terms of predicting and monitoring for POAF. 
Key words: atrial fibrillation, inflammation, C-reactive protein, cytokines, interleukins, review, meta-analysis
Kardiol Pol 2018; 76, 2: 440–451
INTRODUCTION
Postoperative atrial fibrillation (POAF) is a leading arrhythmia 
with serious clinical implications after cardiac surgery, pre-
cipitating a wide spectrum of complications and morbidities, 
such as haemodynamic instability, thromboembolism, tran-
sient ischaemic attack, stroke, end organ failure, prolonged 
hospitalisation, and associated increase in health care costs 
and mortality [1, 2]. Atrial fibrillation (AF) is diagnosed in 
up to 50% of patients after coronary artery bypass grafting 
(CABG) and in over 60% of patients after combined CABG 
and valve surgery with incidence peaks occurring the first 
three days after surgery [2, 3]. AF is based on highly complex 
and multifactorial pathophysiological mechanisms, such as 
oxidative stress, inflammation, prothrombotic state, and 
sympathetic/parasympathetic activation [3, 4]. An appropriate 
modality for diagnosis and monitoring of AF should, on the 
one hand, facilitate preventive and therapeutic measures by 
timely diagnosis, and, on the other hand, not burden patients 
with excessive healthcare costs, while being applicable in 
a majority of health centres worldwide [4]. Administration of 
antiarrhythmic and antioxidant therapeutics for prevention 
or treatment of AF can reduce its incidence and recurrence 
rate. Simple surgical method such as posterior pericardiotomy 
may reduce the risk of POAF [3, 4].
As is widely known, cardiac surgery and the use car-
diopulmonary bypass (CPB) are associated with systemic 
inflammatory response including activation of clotting factors, 
platelets and fibrinolysis, increase in inflammatory cytokines, 
and activation of endothelial and leukocyte responses [5, 6]. 
AF is also associated with infiltration of immune cells and 
proteins mediating inflammatory response in cardiac tissue 
and circulatory processes [5, 6]. 
Various studies have been recently published focusing on 
the relationship between inflammation and the occurrence of 
POAF. However, so far, the data from the studies have been 
largely inconclusive. This comprehensive meta-analysis sought 
to determine the strength of evidence for evaluating the asso-
ciation of baseline and postoperative levels of high-sensitivity 
C-reactive protein (CRP) and interleukins (IL), such as IL-1, 
IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12, 
IL-13, IL-15, and IL-17 with the occurrence of POAF.
METHODS
Literature search 
A comprehensive search was performed by four co-authors 
independently in electronic medical databases (Medline/Pub-
Med, Web of Science, Embase, Science Direct, and Google 
Scholar) from their inception through 10th May 2017 to iden-
tify relevant studies on the association of measured baseline 
(from one week before surgery) and postoperative levels (until 
one week after surgery) of inflammatory markers, such as CRP 
and interleukins 1–17, with the occurrence of AF after isolated 
CABG, valvular surgery, or combined procedures. Predefined 
keywords for searching were: “C-reactive protein”, “CRP”, 
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“acute phase reactant”, “interleukin”, “interleukin-1”, “IL-1”, 
“interleukin-2”, “IL-2”, “interleukin-3”, “IL-3”, “interleukin-4”, 
“IL-4”, “interleukin-5”, “IL-5”, “interleukin-6”, “IL-6”, “in-
terleukin-7”, “IL-7”, “interleukin-8”, “IL-8”, “interleukin-9”, 
“IL-9”, “interleukin-10”, “IL-10”, “interleukin-11”, “IL-11”, 
“interleukin-12”, “IL-12”, “interleukin-13”, “IL-13”, “inter-
leukin-15”, “IL-15”, “interleukin-17”, “IL-17”, and “atrial 
fibrillation”, “supraventricular arrhythmia”, “cardiac surgery”, 
“open heart surgery”, “cardiovascular surgery”, “coronary 
artery bypass surgery”, “CABG”, “valvular surgery”, and “sur-
gery”. There were no limitations for the sample size of the 
studies, time, and language of publications. Abstracts without 
peer-review or those only published as congress presentations 
were not enrolled in the meta-analysis. Two investigators 
checked to find additional studies not indexed in medical 
databases by searching in retrieved references of the enrolled 
studies, recent published review articles, and meta-analyses.
Study selection 
Studies that met the following inclusion criteria were enrolled 
in the analysis: 1) human subjects; 2) case-control or cohort 
studies; 3) patients undergoing either CABG or heart valve 
surgery, or a combination of both; 4) comparing patients 
with POAF and postoperative sinus rhythm (POSR) in terms 
of inflammatory markers.  
Data extraction and outcome measures 
Six investigators (SA-H-S, AS, M-RL, SY, M-PS, and SJM) inde-
pendently extracted the data, whereas two of them integrated 
and compared all of the filled checklists. A consensus stand-
ardised abstraction checklist was applied for recording data in 
each enrolled study in order to resolve the discrepancies. The 
following items were examined through subgroup analyses 
of disparities in the patients’ characteristics for exploration 
of heterogeneity among the studies: 1) year of publication 
(before 2000 vs. after 2000); 2) geographical area (Africa, 
Asia, Europe, North-America, Oceania, South-America); 
3) type of study (case-control vs. cohort); 4) number of pa-
tients (≤ 200 vs. > 200); 5) average age (≤ 60 vs. > 60 years); 
6) percentage of male patients (≤ 70% vs. > 70%); 7) his-
tory of diabetes mellitus (≤ 30% vs. > 30%); 8) history of 
arterial hypertension (≤ 70% vs. > 70%); 9) history of ciga-
rette smoking (≤ 30% vs. > 30%); 10) history of myocardial 
infarction (≤ 20% vs. > 20%); 11) baseline left ventricular 
ejection fraction (≤ 50% vs. > 50%); 12) preoperative use of 
medications, such as diuretics, beta-blockers, statins, angio-
tensin converting enzyme inhibitors or angiotensin receptor 
blockers (for each: ≤ 70% vs. > 70%); 13) type of surgical 
procedure (isolated CABG, isolated valvular surgery, combined 
procedures); 14) utilisation of CPB (on-pump vs. off-pump); 
15) status of surgery (elective, non-elective); 16) duration of 
cross clamping (≤ 60 min vs. > 60 min); and 17) duration of 
CPB (≤ 100 min vs. > 100 min).
Homogenisation of extracted data 
Continuous data were expressed as mean ± standard deviation 
(SD). In cases when interquartile ranges were reported, the mean 
was calculated as [minimum + maximum + 2 (median)]/4 and 
SD as (maximum – minimum)/4 for groups with sample sizes of 
n ≤ 70, and (maximum – minimum)/6 for n > 70 [7].
Quality assessment and statistical analysis 
Two investigators (LM and MG) evaluated the Newcastle- 
-Ottawa scale and design of the studies to assess the quality of 
the studies [8]. Total scores ranged between 0 (worst) and 9 (best 
quality) for case-control or cohort studies. For non-categorical 
data, pooled effect size was presented as standard mean dif-
ference (SMD) with 95% confidence interval (CI). Significant 
heterogeneity was found among the studies considering 
p value < 0.1 for Q test or I2 > 50%. Heterogeneity among 
the trials was tested by applying a random effect model when 
indicated. Begg’s test, which examines the presence of asso-
ciation between effect estimates and their variances, was used 
to evaluate publication bias. P values < 0.05 were considered 
statistically significant. Data analysis was carried out by STATA 
(version 11.0, Stata Corporation, College Station, Texas) using 
METAN and METABIAS commands.
RESULTS
Literature search strategy and included studies 
A total of 1014 studies were extracted from the literature 
search and screened databases, of which 972 were excluded 
after detailed evaluation through the first review for unneces-
sary information (n = 870), insufficient report of endpoints 
of interest (n = 95), or reports on non-matched data (n = 7). 
Finally, 42 studies with a total of 8398 patients were included 
in the present meta-analysis [9–50] (Details about excluded 
and included studies are shown in Supplemental Table 1 
— see journal website).
Association of baseline levels of inflammatory 
markers with the occurrence of POAF 
CRP. A total of 7671 patients were enrolled from 36 studies, 
of which 2240 were assigned to the POAF and 5431 to the 
POSR group (Table 1). The sample size of included studies 
ranged from 20 to 1138 cases (Table 1). Mean baseline level 
of CRP was 13.16 mg/L in the POAF group and 10.46 mg/L 
in the POSR group (Table 2). Pooled analysis showed that the 
mean baseline level of CRP was significantly higher in patients 
with POAF (positive predictor) than POSR cases, with SMD 
0.457 mg/L (95% CI 0.405 to 0.509; p < 0.001) using the 
random effect model (Fig. 1), with considerable heterogeneity 
among the studies (I2 = 95.5%; heterogeneity p < 0.001). 
Interleukins. A total of 649 cases were selected from six 
studies on IL-6, of whom 237 were allocated to the POAF 
group and 412 to the POSR group (Table 1). Mean baseline 
level of IL-6 was 15.1 pg/mL in the POAF and 10.6 pg/mL 
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in the POSR group (Table 2). Pooled analysis indicated that 
IL-6 was significantly higher in patients with POAF (positive 
predictor) compared to POSR with SMD of 0.398 pg/mL (95% 
CI 0.227 to 0.569; p < 0.001, I2 = 92.1%; heterogeneity 
p = 0.001; Fig. 2). Regarding pooled assessment analysis, 
both groups were similar regarding the baseline level of 
IL-8 (number of studies = 2, SMD –0.09 pg/mL, 95% CI 
–0.37 to 0.19; p = 0.54 and I2 = 72.6%; heterogeneity 
p = 0.05, Supplemental Figure 1 — see journal website) 
and IL-10 (number of studies = 3, SMD –0.241 pg/mL, 95% 
CI –0.50 to 0.018; p = 0.06 and I2 = 0.0%; heterogeneity 
p = 0.39, Supplemental Figure 2 — see journal website). 
There were no reports comparing baseline levels of other 
interleukins between POAF and POSR.
Association of postoperative levels of inflammatory 
markers with the occurrence of POAF
CRP. A total of 5382 cases were included from 23 studies, of 
which 1605 were assigned to the POAF group and 3777 to 
the POSR group (Table 1). Mean postoperative level of CRP 
was 240.7 mg/L in the POAF group and 219.9 mg/L in the 
POSR group (Table 2). Pooled analysis showed that the mean 
postoperative level of CRP was significantly higher in patients 
with POAF (positive predictor) than POSR patients, with 
SMD 0.576 mg/L (95% CI 0.512 to 0.636; p < 0.001) utilis-
ing the random effect model (Fig. 3). There was remarkable 
heterogeneity among the studies (I2 = 96.4%; heterogeneity 
p < 0.001). 
Interleukins. Regarding pooled assessment analysis, there 
were more patients with POAF regarding the postoperative 
level of IL-6 as compared to POSR (number of studies = 5, 
SMD 1.66 pg/mL, 95% CI 1.42 to 1.89; p < 0.001, and 
I2 = 93.0%; heterogeneity p = 0.001, Fig. 4), IL-8 (number 
of studies = 3, SMD 0.839 pg/mL, 95% CI 0.620 to 1.057; 
p < 0.001, and I2 = 98.1%; heterogeneity p = 0.001, Supple-
mental Figure 3 — see journal website), and IL-10 (number 
of studies = 4, SMD 0.590 pg/mL, 95% CI 0.395 to 0.785; 
p < 0.001, and I2 = 90.0%; heterogeneity p = 0.001, Supple- 
mental Figure 4 — see journal website). There were no 
reports comparing postoperative levels of other interleukins 
between POAF and POSR.
Publication bias and subgroup analysis 
Begg’s tests showed that all analyses were without publica-
tion bias except for the relationship between baseline level 
of CRP and the occurrence of POAF (Supplemental Figures 
5–12 — see journal website). Classification in relation to 
potential heterogeneity agents and subgroup analyses are 
reported in detail in Supplemental Tables 2 and 3 (see 
journal website), respectively.
DISCUSSION
Postoperative AF is considered a serious and common post-
operative complication with a peak incidence in the first Ta
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Table 2. Information about haematological indices and their levels in each study 
First author [reference] Markers Levels
Measurement of inflammatory markers 
Xu [9] CRP Preoperative: CRP [AF: 4.52 ± 2.88 vs. SR: 3.99 ± 3.48]
Postoperative: CRP [AF: 29.35 ± 19.1 vs. SR: 24.98 ± 12.68]
Saskin [10] CRP Preoperative: CRP [AF: 1.64 ± 0.76 vs. SR: 0.85 ± 0.35]
Saskin [11] CRP Preoperative: CRP [AF: 10.3 ± 8.3 vs. SR: 5.4 ± 2.9]
Postoperative: CRP [AF: 309 ± 34 vs. SR: 249 ± 48]
Cerit [12] CRP Preoperative: CRP [AF: 21 ± 47 vs. SR: 9 ± 14]
Anatolevna [13] CRP, IL-6, IL-8, IL-10 Preoperative:  
CRP [AF: 1.4 ± 1.3 vs. SR: 1.2 ± 0.93]
IL-6 [AF: 30.1 ± 26.5 vs. SR: 25.7 ± 13.2]
IL-8 [AF: 2.7 ± 2.4 vs. SR: 2.2 ± 1.3]
IL-10 [AF: 6.3 ± 3.3 vs. SR: 7.4 ± 4.7]
Postoperative:  
CRP [AF: 4.7 ± 0.7 vs. SR: 4.5 ± 0.8]
IL-6 [AF: 72.7 ± 60.8 vs. SR: 38 ± 34.6]
IL-8 [AF: 11.9 ± 6 vs. SR: 7.7 ± 5.4]
IL-10 [AF: 11.9 ± 6.4 vs. SR: 11.6 ± 5.7]
Gecmen [14] CRP Preoperative: CRP [AF: 33.9 ± 27.5 vs. SR: 27.5 ± 22.7]
Korantzopoulos [15] CRP Preoperative: CRP [AF: 83.25 ± 49.75 vs. SR: 43.75 ± 1.6]
Erdem [16] CRP Preoperative: CRP [AF: 10.6 ± 8.5 vs. SR: 5.6 ± 6.5]
Narducci [17] CRP Preoperative: CRP [AF: 10.4 ± 4.2 vs. SR: 5.67 ± 2.72]
Postoperative: CRP [AF: 41.35 ± 3.25 vs. SR: 45.95 ± 5.25]
Limite [18] CRP Preoperative: CRP [AF: 2.92 ± 0.28 vs. SR: 2.95 ± 0.3]
Postoperative: CRP [AF: 196.92 ± 25.65 vs. SR: 172.2 ± 20.46]
Erdem [19] CRP Preoperative: CRP [AF: 8.9 ± 19.6 vs. SR: 5.3 ± 8.7]
Pilatis [20] CRP Preoperative: CRP [AF: 4.82 ± 1.47 vs. SR: 3.95 ± 0.51]
Postoperative: CRP [AF: 114.78 ± 11 vs. SR: 128.25 ± 7.83]
Cao [21] CRP Preoperative: CRP [AF: 5.76 ± 1.61 vs. SR: 2.73 ± 0.94]
Bjorgvinsdottir [22] CRP, IL-8, IL-10 Preoperative:  
IL-8 [AF: 12 ± 8 vs. SR: 14.75 ± 10.75]
IL-10 [AF: 30.75 ± 22.75 vs. SR: 40.75 ± 31.75]
Postoperative:  
CRP [AF: 221.25 ± 95 vs. SR: 199.5 ± 84]
IL-8 [AF: 54.5 ± 50.5 vs. SR: 92 ± 88]
IL-10 [AF: 71 ± 54.25 vs. SR: 68 ± 51.5]
Sabol [23] CRP Postoperative: CRP [AF: 138.1 ± 41.1 vs. SR: 69.9 ± 25.8]
Garcia [24] CRP Preoperative: CRP [AF: 24 ± 23 vs. SR: 25 ± 27]
Skuladottir [25] CRP Postoperative: CRP [AF: 221.25 ± 95 vs. SR: 199.5 ± 84]
Gabrielli [26] CRP Preoperative: CRP [AF: 68 ± 14 vs. SR: 57 ± 12]
Kaireviciute [27] CRP, IL-6 Postoperative:  
CRP [AF: 4.47 ± 1.57 vs. SR: 2.15 ± 0.56]
IL-6 [AF: 39.8 ± 20.6 vs. SR: 20.9 ± 9.3]
Gasparovic [28] CRP Preoperative: CRP [AF: 6 ± 16 vs. SR: 6 ± 13]
Postoperative: CRP [AF: 149 ± 82 vs. SR: 137 ± 72]
Gibson [29] CRP Preoperative: CRP [AF: 2.44 ± 0.69 vs. SR: 1.91 ± 0.5]
Postoperative: CRP [AF: 175.5 ± 13.66 vs. SR: 163.25 ± 8.83]
Ji [30] CRP Postoperative: CRP [AF: 165.7 ± 29.4 vs. SR: 105.3 ± 18.7]
Girerd [31] CRP, IL-6 Preoperative:  
CRP [AF: 1.95 ± 2.67 vs. SR: 1.49 ± 2.74]
IL-6 [AF: 2.3 ± 1.6 vs. SR: 2.2 ± 2.1]
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Table 2 (cont). Information about haematological indices and their levels in each study
First author [reference] Markers Levels
Choi [32] CRP Preoperative: CRP [AF: 6.6 ± 12.7 vs. SR: 4.7 ± 11.4]
Postoperative: CRP [AF: 177.1 ± 99.2 vs. SR: 150.3 ± 55.7]
Antoniades [33] CRP Preoperative: CRP [AF: 1.4 ± 0.55 vs. SR: 1.52 ± 0.42]
Sezai [34] CRP Preoperative: CRP [AF: 6.9 ± 17.4 vs. SR: 11.9 ± 27.9]
Postoperative: CRP [AF: 45.6 ± 29.2 vs. SR: 47.1 ± 29]
Fontes [35] CRP Preoperative: CRP [AF: 12 ± 22 vs. SR: 13 ± 18]
Postoperative: CRP [AF: 189 ± 74 vs. SR: 179 ± 54]
Ziabakhsh-Tabari [36] CRP, IL-6 Preoperative:  
CRP [AF: 10.42 ± 9.58 vs. SR: 8.4 ± 4.9]
IL-6 [AF: 3.95 ± 1.02 vs. SR: 1.24 ± 0.8]
Postoperative: CRP [AF: 175.3 ± 60.1 vs. SR: 175.4 ± 64.4]
Mehmet OC [[37] CRP Preoperative: CRP [AF: 5.4 ± 3.1 vs. SR: 6.5 ± 4.4]
Postoperative: CRP [AF: 4.6 ± 1.7 vs. SR: 5 ± 1.4]
Canbaz [38] CRP, IL-6, IL-10 Preoperative:  
CRP [AF: 23 ± 17 vs. SR: 17 ± 14]
IL-6 [AF: 11 ± 19 vs. SR: 9 ± 11]
IL-10 [AF: 60 ± 80 vs. SR: 50 ± 80]
Postoperative:  
CRP [AF: 53 ± 17 vs. SR: 45 ± 17]
IL-6 [AF: 38 ± 36 vs. SR: 27 ± 37]
IL-10 [AF: 190 ± 130 vs. SR: 120 ± 150]
Qian [39] CRP Preoperative: CRP [AF: 2.73 ± 1.73 vs. SR: 2.34 ± 1.54]
Pretorius [40] CRP, IL-6, IL-8, IL-10 Postoperative:  
CRP [AF: 13.1 ± 3.6 vs. SR: 14.1 ± 2.6]
IL-6 [AF: 380.6 ± 151.1 vs. SR: 174.8 ± 16.9]
IL-8 [AF: 85.2 ± 63.1 vs. SR: 18.6 ± 2.3]
IL-10 [AF: 2712.5 ± 298.6 vs. SR: 2463.6 ± 162]
Ucar [41] CRP, IL-6 Preoperative:  
CRP [AF: 0.6 ± 0.2 vs. SR: 0.3 ± 0.2]
IL-6 [AF: 7.4 ± 3.6 vs. SR: 6.2 ± 2.9]
Postoperative:  
CRP [AF: 22.4 ± 4.1 vs. SR: 16.9 ± 1.9]
IL-6 [AF: 100.7 ± 65.8 vs. SR: 36.9 ± 15.9]
Ahlsson [42] CRP Preoperative:  
CRP [AF: 5.6 ± 9.1 vs. SR: 5 ± 6.4]
Postoperative: CRP [AF: 175.3 ± 60.1 vs. SR: 175.4 ± 64.4]
Houge JR [43] CRP Preoperative: CRP [AF: 13.3 ± 2.5 vs. SR: 11.7 ± 1.4]
Ishida [44] IL-6 Postoperative: IL-6 [AF: 435 ± 175 vs. SR: 247 ± 102]
Lo [45] CRP Preoperative: CRP [AF: 4.07 ± 1.57 vs. SR: 1.7 ± 0.45]
Cosgrave [46] CRP Preoperative: CRP [AF: 26.05 ± 7.25 vs. SR: 36.07 ± 8.05]
Postoperative: CRP [AF: 2372.5 ± 297.5 vs. SR: 2532.5 ± 201.6]
Mandal [47] CRP Preoperative: CRP [AF: 2.4 ± 1.2 vs. SR: 1.95 ± 1]
Fontes [48] CRP Preoperative: CRP [AF: 2.2 ± 3.2 vs. SR: 1.8 ± 2.1]
Wang [49] CRP Preoperative: CRP [AF: 43 ± 38 vs. SR: 39 ± 36]
Postoperative: CRP [AF: 542 ± 279 vs. SR: 219 ± 164]
Mandal [50] CRP Preoperative: CRP [AF: 1.92 ± 0.97 vs. SR: 2.56 ± 0.8]
AF — atrial fibrillation; CRP — C-reactive protein [mg/L]; IL — interleukin [pg/mL]; SR — sinus rhythm
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three days after cardiac surgery [51]. POAF is of high clinical 
importance for its negative effects on short-, average-, and 
long-term clinical outcomes. Despite good response to 
therapy and a number of treatment modalities for this com-
mon arrhythmia, preliminary diagnosis of POAF as well as 
prophylactic therapy could prevent potential complications 
and morbidities, lower health care costs, mortality rates, and 
reduce length of stay in intensive care unit and in hospital.
On the other hand, it is well-known that coronary artery 
disease is considered one of the most important and common 
Figure 1. Forest plot of standard mean difference (SMD) for association between baseline level of C-reactive protein and  
occurrence of postoperative atrial fibrillation; CI — confidence interval; Pub — publication
Figure 2. Forest plot of standard mean difference (SMD) for association between baseline level of interleukin-6 and occurrence of 
postoperative atrial fibrillation; CI — confidence interval; Pub — publication
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chronic diseases, while CABG is being extensively performed 
worldwide as an appropriate revascularisation procedure for this 
disease [51–53]. The incidence of POAF after CABG is significant 
accounting for ca. 50% of patients after surgery. In this respect, 
diagnosis, prophylaxis, treatment, and follow-up of POAF require 
a large  number of laboratory and clinical investigations [51–53].
Today, inflammation is believed to be a critical pathological 
mechanism responsible for AF. Firstly, patients with coronary 
artery disease often present with preoperative chronic inflam-
matory state with physiological and cardiac haemodynamic 
changes or coexisting co-morbidities [54–56]. Secondly, a major 
inflammatory response develops during surgery and is related to 
a wide range of factors, such as surgical trauma, CPB, and organ 
reperfusion injury [55, 56]. Thirdly, myocardial ischaemia, rep-
erfusion, and re-oxygenation activate further pro-inflammatory 
processes [57, 58]. Evidence increasingly supports the influence 
Figure 3. Forest plot of standard mean difference (SMD) for association between postoperative level of C-reactive protein and 
occurrence of postoperative atrial fibrillation; CI — confidence interval; Pub — publication
Figure 4. Forest plot of standard mean difference (SMD) for association between postoperative level of interleukin-6 and  
occurrence of postoperative atrial fibrillation; CI — confidence interval; Pub — publication
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of an acute inflammation on the pathogenesis of AF, which 
is largely based on association between the white blood cell 
counts and the incidence of AF [57–59]. Patients with higher 
leukocyte count are more likely to develop AF, and patients 
developing AF show higher monocyte activation with increased 
neutrophil-to-lymphocyte ratio [52]. 
In the present meta-analysis, the association of CRP and 
interleukins with the occurrence of new-onset POAF was 
investigated. The results of our study indicated significantly 
higher baseline levels of CRP in patients with POAF compared 
to those with POSR, thus being considered as a positive 
predictor. Subgroup analysis showed that the association of 
baseline CRP with the occurrence of POAF was not related to 
the type of surgery because this association was observed in 
isolated CABG, isolated valvular surgery, as well as combined 
CABG and valvular surgery. Previous research also showed 
an association between AF and CRP in various clinical set-
tings. Yo et al. [60] reported that the level of CRP was directly 
associated with the recurrence of AF patients who underwent 
cardioversion, thus being a positive predictor. Rezaei et al. [61] 
showed that treatment with anti-inflammatory drugs not only 
decreased levels of CRP, but also decreased the occurrence 
of AF. Therefore, they affirmed a direct relationship between 
CRP levels as an inflammatory marker and the occurrence 
of AF [61]. 
Our findings also revealed that higher postoperative 
levels of CRP were associated with the occurrence of AF. In 
total, it can be concluded that measuring CRP levels before 
surgery, during postoperative intensive care unit stay, and on 
the ward can obviously warn of the risk of AF occurrence 
and help clinicians as an additional source for diagnosis and 
monitoring purposes. 
According to the literature, interleukins are believed to be 
capable of modulating cardiovascular function by a variety of 
mechanisms, including promotion of left ventricle remodel-
ling, induction of contractile dysfunction, and changing the 
response of myocardial B-adrenergic receptors [57–59]. Thus, 
our findings regarding involvement of various interleukins in 
pathophysiological mechanisms of development of POAF 
might be supported by this previous evidence.  
On the other hand, it is noteworthy that in light of previ-
ous findings, a number of inflammatory mediators generated 
in response to CPB and ischaemia-reperfusion could contrib-
ute to cardiac functional depression and apoptosis [57–59]. 
Among other things, these changes may alter electrical activity 
and trigger arrhythmias [57–59]. The present study demon-
strated that the baseline level of IL-6 was significantly higher 
in patients with POAF compared to POSR and could be used 
as a pre-operative positive predictor. Interestingly, the baseline 
levels of IL-8 and IL-10 were not significantly different in the 
two groups. On the other hand, measuring interleukin levels 
after surgery indicated that IL-6, IL-8, and IL-10 were much 
higher in the POAF group than in the POSR group.
Consequently, IL-6 can be introduced as an inflamma-
tory marker sensitive to the physiological changes of cardiac 
tissue before surgery and prior to activation and release of 
other inflammatory markers during surgery [57–59]. It should 
be noted that after surgery an increase in other interleukins 
was probably observed due to perioperative trauma, CPB, 
and myocardial ischaemia-reperfusion. Zakkar et al. [57] 
pointed out that cytokines, particularly IL-6, IL-8, and IL-10, 
significantly increased during and following cardiac surgery 
and might influence the occurrence of AF as acute-inflam-
matory markers [57].
Limitations of the study
This review is a study-level meta-analysis with a natural lack 
of available data on end-points assessed in studies included 
in the meta-analysis. Also, there are different definitions of 
arrhythmia and sinus rhythm between studies and there is 
a lack of data on different types of surgical procedures. 
CONCLUSIONS
Finally, we can conclude that inflammation is proposed as 
a possible mechanism in pathogenesis of POAF. Measuring 
the levels of inflammatory markers such as CRP, IL-6, IL-8, 
and IL-10 perioperatively can work as positive predictors for 
POAF. Therefore, these inflammatory markers should be taken 
into account during the hospital stay of patients referred for 
cardiac surgery, because they might help clinicians in terms 
of prediction, diagnosis, and monitoring of POAF. Another 
limitation that should be addressed in future studies is po-
tential use of prophylactic treatment for POAF as a response 
to increased levels of inflammatory markers with the view to 
preventing the occurrence of this arrhythmia and its conse-
quent complications.
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